Related Experiment Video

Updated: Jun 13, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Lentivirus-mediated knockdown of cyclin Y (CCNY) inhibits glioma cell proliferation

YongGang Xu1, Zhi Wang, Jie Wang

  • 1Department of Minimally Invasive Neurosurgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.

Oncology Research
|May 6, 2010
PubMed

Insights

Cyclin Y (CCNY) is a novel protein implicated in cancer. CCNY knockdown inhibited glioma cell proliferation and cell cycle progression, suggesting its role in glioma tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cyclin Y (CCNY) is a newly identified cyclin with largely unknown functions.
  • Its role in human cancers, particularly glioma, remains largely unexplored.

Purpose of the Study:

  • To investigate the expression and functional role of CCNY in glioma.
  • To determine if CCNY influences glioma cell proliferation and cell cycle progression.

Main Methods:

  • Utilized lentivirus-mediated RNA interference (RNAi) to achieve CCNY knockdown in glioma cells.
  • Assessed the impact of CCNY knockdown on cell proliferation, colony formation, and cell cycle progression.

Main Results:

  • Lentivirus-mediated RNAi effectively downregulated CCNY expression in glioma cells.
  • CCNY knockdown significantly inhibited glioma cell proliferation and colony formation.
  • Suppression of CCNY impaired cell cycle progression in glioma cells.

Conclusions:

  • CCNY plays a significant role in promoting glioma cell proliferation and tumorigenesis.
  • Targeting CCNY may represent a potential therapeutic strategy for glioma.

More Related Videos

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.